5 Key Takeaways

• 1

  The AHA's statement addresses pediatric hypertriglyceridemia, affecting 10% to 20% of US children and adolescents.

• 2

  Severe hypertriglyceridemia increases the risk of acute pancreatitis and atherosclerotic cardiovascular disease later in life.

• 3

  Lifestyle modifications, including dietary changes and physical activity, are recommended as first-line therapy for managing hypertriglyceridemia.

• 4

  No FDA-approved drugs exist for pediatric hypertriglyceridemia; pharmacotherapy may be considered for persistent high levels.

• 5

  The statement emphasizes the need for further research on triglyceride-lowering therapies and lifestyle interventions in children.